Shanghai Huaota Biopharmaceutical
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (16)
HB0025-C-0301: A Study to Investigate HB0025 Combined With Chemotherapy as First-Line Treatment for Advanced or Recurrent MMR-proficient Endometrial Cancer
Started: 10/20/2026
Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer
Started: 1/15/2026
Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Started: 1/15/2026
Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
Started: 2/29/2024
Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
Started: 9/2/2024
Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
Started: 3/19/2025
A Study to Evaluate HB0034 in Healthy Chinese Adult Participants
Started: 12/6/2024
A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
Started: 8/25/2022
A Study of HB0056 in Adult Participants With Moderate to Severe Asthma
Started: 8/21/2025
A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.
Started: 3/27/2026
A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants
Started: 11/18/2024
A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants
Started: 6/3/2025
A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors
Started: 9/1/2024
A Study to Evaluate Multi-dose of HB0034 in Healthy Adult Participants
Started: 10/13/2022
HB0034 in Patients With Generalized Pustular Psoriasis (GPP)
Started: 11/6/2022
A Study to Evaluate HB0034 in Healthy Adult Participants
Started: 12/3/2021